Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Gil

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Nature Communications|June 8, 2021
Common variants in Alzheimer's disease and risk stratification by polygenic risk scoresItziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, et al.
Nature Communications|February 9, 2023
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scoresItziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Josef Thaler, Richard Greil, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Nature Communications|June 8, 2021
Common variants in Alzheimer's disease and risk stratification by polygenic risk scoresItziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, et al.
Nature Communications|February 9, 2023
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scoresItziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Josef Thaler, Richard Greil, et al.
Pageof 7